Tom Mikkelsen
Impact in
- Genetics top 0.01%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 148
- Glioma Diagnosis and Treatment 145
-
- Cancer, Hypoxia, and Metabolism 19
- Co-authors
- Timothy F. CloughesyPatrick Y. WenMark L. RosenblumDavid A. ReardonNina A. PaleologosLisa ScarpaceRoger StuppDavid Schiff
- Journals
- Journal of Neuro-Oncology (40 papers)Neuro-Oncology (36 papers)Journal of Clinical Oncology (27 papers)Neurosurgery (10 papers)Oncotarget (7 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
Tom Mikkelsen
249 papers receiving 18.6k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Genetics 9.9k
- Cancer Research 4.2k
- Radiology, Nuclear Medicine and Imaging 4.1k
- Oncology 4.1k
- Immunology and Allergy 803
Countries citing papers authored by Tom Mikkelsen
This map shows the geographic impact of Tom Mikkelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Mikkelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Mikkelsen more than expected).
Fields of papers citing papers by Tom Mikkelsen
This network shows the impact of papers produced by Tom Mikkelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Mikkelsen. The network helps show where Tom Mikkelsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Mikkelsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2020 | 37 | |
| 5 | First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy | 2019 | 1 |
| 6 | 2018 | 18 | |
| 7 | 2013 | 91 | |
| 8 | 2013 | 73 | |
| 9 | 2013 | 36 | |
| 10 | 2012 | 17 | |
| 11 | 2011 | 67 | |
| 12 | Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Hit paper breakdown → | 2009 | 1855 |
| 13 | 2009 | 131 | |
| 14 | 2007 | 90 | |
| 15 | 2004 | 144 | |
| 16 | 2002 | 166 | |
| 17 | Carboxyamido-triazole induces apoptosis in bovine aortic endothelial and human glioma cells. | 2000 | 25 |
| 18 | 1999 | 80 | |
| 19 | Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. | 1996 | 119 |
| 20 | Clonal expansion of p53 mutant cells is associated with brain tumour progression Hit paper breakdown → | 1992 | 578 |
About Tom Mikkelsen
Tom Mikkelsen is a scholar working on Genetics, Cancer Research, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 258 papers that have together received 18.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (145 papers), Brain Metastases and Treatment (44 papers), MRI in cancer diagnosis (33 papers), Radiomics and Machine Learning in Medical Imaging (27 papers), Advanced MRI Techniques and Applications (26 papers), Cancer, Hypoxia, and Metabolism (19 papers), Cancer Treatment and Pharmacology (16 papers) and Cell Adhesion Molecules Research (16 papers). The work is most often cited by research in Genetics (9.9k citations), Cancer Research (4.2k citations), Radiology, Nuclear Medicine and Imaging (4.1k citations), Oncology (4.1k citations) and Immunology and Allergy (803 citations). Tom Mikkelsen has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Timothy F. Cloughesy, Patrick Y. Wen, Mark L. Rosenblum, David A. Reardon, Nina A. Paleologos, Lisa Scarpace, Roger Stupp, David Schiff, Steven N. Kalkanis and Marc C. Chamberlain. Their work appears in journals such as Journal of Neuro-Oncology, Neuro-Oncology, Journal of Clinical Oncology, Neurosurgery and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.